Skip to main content
. Author manuscript; available in PMC: 2013 Aug 9.
Published in final edited form as: Virology. 2008 Sep 18;380(2):285–295. doi: 10.1016/j.virol.2008.07.007

Fig. 5.

Fig. 5

In the presence of 5 ug/ml of sCD4, GP vaccine sera neutralized subtype C virus TV1.29 predominantly via anti-V3 antibodies. A V3 peptide (30 ug/ml) matched to the subtype C vaccine immunogen was used to inhibit the V3-mediated neutralization by the sera. A scrambled V3 peptide had no inhibitory effect (not shown).